D

DoseSpot

ePrescribing software with API integrations

Overview

DoseSpot provides ePrescribing software that lets clinicians prescribe medications safely, securely, and efficiently. The platform is cloud-based and API-driven, with Surescripts and EPCS Drummond certifications and customizable integrations that fit into existing clinical workflows for medical and dental practices, healthcare systems, and other innovators. Its speed and reliability, up to five times faster than some competing ePrescribing products, support faster prescribing and help tailor medication options to patients’ insurance coverage. DoseSpot differentiates itself through its certifications, seamless API integrations that reduce training, and a scalable subscription model designed to be affordable for a wide range of providers, with a goal to help providers comply with state and federal regulations while improving operational efficiency and patient care.

Significant Headcount Growth

Work here?Claim your company

About DoseSpot

Simplify's Rating
Why DoseSpot is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Waltham, MA

Founded

2009

Get referred to DoseSpot

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Interra Health said it was profitable and growing about 40% in March 2026.
  • The company said 50 million prescriptions move through DoseSpot annually, proving transaction scale.
  • Adoption momentum improved after the March 2026 merger and Adam Gail’s CRO hire.

What critics are saying

  • Epic, Oracle, and Surescripts can bundle similar workflows, compressing pricing by 2027.
  • Interra Health depends on payer and pharmacy data pipes; a major integration break cripples adoption.
  • If Bain Capital demands faster growth, product sprawl can distract Josh Weiner and erode DoseSpot’s core.

What makes DoseSpot unique

  • Interra Health unifies DoseSpot prescribing with Arrive Health benefits data for point-of-care decisions.
  • DoseSpot’s platform spans 140+ APIs, customized workflows, and 800,000 prescribers across settings.
  • DoseSpot and pVerify combine ePrescribing, eligibility, and revenue-cycle tools in one workflow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Health Savings Account/Flexible Spending Account
  • Unlimited Paid Time Off
  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Parental Leave
  • 401(k) Company Match

Growth & Insights and Company News

6 month growth

3%

1 year growth

25%

2 year growth

30%
GlobeNewswire
Mar 2nd, 2026
Bain Capital backs DoseSpot-Arrive Health merger to form Interra Health, transforming prescription transparency for 800,000 providers

Interra Health has been formed through the merger of DoseSpot and Arrive Health, creating a platform that provides real-time coverage, pricing and pharmacy information to providers and patients during prescribing decisions. The merger is backed by Bain Capital Tech Opportunities as majority owner, with PSG, Providence and UPMC Enterprises as minority investors. The company combines Arrive Health's coverage and pricing network with DoseSpot's ePrescribing capabilities to help patients access medications at the lowest cost. Josh Weiner, former DoseSpot CEO, will lead the combined company, whilst Kyle Kiser, former Arrive Health CEO, becomes senior adviser and board member. Interra Health currently serves approximately 800,000 prescribers and reports that one-third of patients change their pharmacy after reviewing available options through the platform.

Fierce Healthcare
Feb 19th, 2025
ViVE 2025 roundup: Lumeris unveils AI tech for primary care; DoseSpot's latest Rx transparency tool

Electronic prescribing solution company DoseSpot launched Connect, a suite of tools that gives patients quick access to pharmacies offering the lowest price for their prescribed medication.

PR Newswire
Jun 18th, 2024
DoseSpot Appoints Adam Gail as Chief Revenue Officer to Spearhead Next Phase of Growth

DoseSpot appoints Adam Gail as Chief Revenue Officer to spearhead next phase of growth.

Business Wire
Jun 8th, 2023
PSG-Backed DoseSpot and pVerify Join Forces to Expand API-Driven Capabilities and Help Improve Patient Access to Healthcare

DoseSpot, a software-as-a-service (SaaS) platform that enables clinicians to write and transmit prescriptions to pharmacies electronically, announced

PitchBook
Jan 27th, 2022
Providence Equity Partners LLC invests into DoseSpot

DoseSpot, the provider of a SaaS platform that helps clinicians electronically write prescriptions and transmit them to pharmacies, has received a growth investment from Providence Strategic Growth.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for DoseSpot right now.

Find jobs on Simplify and start your career today

We update DoseSpot's jobs every few hours, so check again soon!Browse all jobs